[HTML][HTML] Inflammatory rheumatic disorders and bone
IEM Bultink, M Vis, IE van der Horst-Bruinsma… - Current rheumatology …, 2012 - Springer
Inflammatory joint diseases such as rheumatoid arthritis, as well as other rheumatic conditions,
such as systemic lupus erythematosus (SLE) and ankylosing spondylitis, comprise a …
such as systemic lupus erythematosus (SLE) and ankylosing spondylitis, comprise a …
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
GJ Wolbink, M Vis, W Lems, AE Voskuyl… - Arthritis & …, 2006 - Wiley Online Library
Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against
tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This …
tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This …
Can bone loss in rheumatoid arthritis be prevented?
M Vis, M Güler-Yüksel, WF Lems - Osteoporosis International, 2013 - Springer
Rheumatoid arthritis (RA) is a systemic inflammatory disease that can lead to local joint
deformations (bone erosions and joint space narrowing) and to extra-articular phenomena, …
deformations (bone erosions and joint space narrowing) and to extra-articular phenomena, …
[HTML][HTML] Animal models of bone loss in inflammatory arthritis: from cytokines in the bench to novel treatments for bone loss in the bedside—a comprehensive review
Throughout life, bone is continuously remodelled. Bone is formed by osteoblasts, from
mesenchymal origin, while osteoclasts induce bone resorption. This process is tightly regulated. …
mesenchymal origin, while osteoclasts induce bone resorption. This process is tightly regulated. …
Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.
M Vis, MT Nurmohamed, G Wolbink… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: Cardiovascular morbidity and mortality appear to be enhanced in rheumatoid
arthritis (RA), which might be due to an increased prevalence of cardiovascular risk factors …
arthritis (RA), which might be due to an increased prevalence of cardiovascular risk factors …
[HTML][HTML] Sex-specific differences and how to handle them in early psoriatic arthritis
E Passia, M Vis, LC Coates, A Soni… - Arthritis Research & …, 2022 - Springer
Objectives The prevalence of psoriatic arthritis (PsA) is the same in men and women;
however, the latter experience a higher burden of disease and are affected more frequently by …
however, the latter experience a higher burden of disease and are affected more frequently by …
Influence of disease manifestations on health-related quality of life in early psoriatic arthritis
…, JJ Veris-van Dieren, JMW Hazes, M Vis - The Journal of …, 2018 - jrheum.org
Objective. Psoriatic arthritis (PsA) is a multifaceted disease. Affecting joints, skin, entheses,
and dactylitis, its effect on health-related quality of life (HRQOL) could be substantial. We aim …
and dactylitis, its effect on health-related quality of life (HRQOL) could be substantial. We aim …
Performance of screening tools for psoriatic arthritis: a cross-sectional study in primary care
…, AEAM Weel, M van der Ven, M Vis… - …, 2017 - academic.oup.com
Objective. To compare the screening performance of the Psoriasis Epidemiology Screening
Tool (PEST), Psoriatic Arthritis Screening and Evaluation (PASE) and Early Arthritis for …
Tool (PEST), Psoriatic Arthritis Screening and Evaluation (PASE) and Early Arthritis for …
Effect of intramuscular vs intra-articular glucocorticoid injection on pain among adults with knee osteoarthritis: The KIS randomized clinical trial
…, MF Mol, PK Bos, DMJ Dorleijn, M Vis… - JAMA Network …, 2022 - jamanetwork.com
Importance Intra-articular (IA) glucocorticoid injection is widely used in patients with knee
osteoarthritis (OA), but the safety of this technique is in question among physicians. …
osteoarthritis (OA), but the safety of this technique is in question among physicians. …
[PDF][PDF] Burden of psoriatic arthritis according to different definitions of disease activity: comparing minimal disease activity and the disease activity index for psoriatic …
K Wervers, M Vis, I Tchetveriko… - Arthritis Care & …, 2018 - Wiley Online Library
Objective Treat‐to‐target strategies have improved outcomes in rheumatic diseases. In
psoriatic arthritis (PsA), the proposed targets are the multidimensional target minimal disease …
psoriatic arthritis (PsA), the proposed targets are the multidimensional target minimal disease …